Skip to search formSkip to main contentSkip to account menu

Insulin, Short-Acting

Known as: Insulin, Rapid-Acting, Short-Acting Insulin, Rapid-Acting Insulin 
Insulin derivatives and preparations that are designed to induce a rapid HYPOGLYCEMIC EFFECT.
National Institutes of Health

Related topics

Related topics

7 relations

Broader (1)

Hypoglycemic Agents
In BloodProcess of secretionaspects of radiation effectschemical synthesis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin
OBJECTIVE To examine the efficacy and safety of adding the once-daily glucagon-like peptide-1 receptor agonist (GLP-1RA… 
Review
2008
Review
2008
Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state.
CONTEXT Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) cause major morbidity and significant mortality in… 
Review
2004
Review
2004
Islet transplantation as a treatment for diabetes - a work in progress.
Although pancreas transplantation is increasingly being performed in an effort to provide type 1 diabetic patients with the… 
Highly Cited
2004
Highly Cited
2004
Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.
OBJECTIVE Insulin detemir is a soluble long-acting basal insulin analog designed to overcome the limitations of conventional… 
Review
2003
Review
2003
Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
  • D. DeWittI. Hirsch
  • Journal of the American Medical Association (JAMA…
  • 2003
  • Corpus ID: 24627318
CONTEXT Newer insulin therapies, including the concept of physiologic basal-prandial insulin and the availability of insulin… 
Review
2003
Review
2003
Clinical significance, pathogenesis, and management of postprandial hyperglycemia.
It is well established that strict glycemic control (hemoglobin A1c <7.0%) can prevent the microvascular complications of… 
Review
2001
Review
2001
Insulin therapy in type 2 diabetes.
Highly Cited
2000
Highly Cited
2000
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.
In recent years, analogs of human insulin have been engineered with the aim of improving therapy for people with diabetes. To… 
Highly Cited
1998
Highly Cited
1998
Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
OBJECTIVE To compare glycemic control obtained with the new rapid-acting insulin analog insulin aspart with that obtained with… 
Highly Cited
1970
Highly Cited
1970
Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability
Three normal, three stable diabetic, and eight unstable diabetic subjects were investigated, with continuous automated blood… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)